[go: up one dir, main page]

UA102680C2 - Единичная дозированная форма, которая включает привитый сополимер поливинилового спирта-полиэтиленгликоля и стероидный эстроген - Google Patents

Единичная дозированная форма, которая включает привитый сополимер поливинилового спирта-полиэтиленгликоля и стероидный эстроген

Info

Publication number
UA102680C2
UA102680C2 UAA201010636A UAA201010636A UA102680C2 UA 102680 C2 UA102680 C2 UA 102680C2 UA A201010636 A UAA201010636 A UA A201010636A UA A201010636 A UAA201010636 A UA A201010636A UA 102680 C2 UA102680 C2 UA 102680C2
Authority
UA
Ukraine
Prior art keywords
graft copolymer
polyethylene glycol
dosage form
polyvinyl alcohol
unit dosage
Prior art date
Application number
UAA201010636A
Other languages
English (en)
Ukrainian (uk)
Inventor
Адриан Функе
Ильдико Теребези
Саша Генераль
Original Assignee
Байер Интеллектуал Проперти Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39365963&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA102680(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байер Интеллектуал Проперти Гмбх filed Critical Байер Интеллектуал Проперти Гмбх
Priority claimed from PCT/EP2009/000904 external-priority patent/WO2009100871A2/en
Publication of UA102680C2 publication Critical patent/UA102680C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)

Abstract

Изобретение относится к единичной дозированной форме, которая включает матрикс тонкой водорастворимой пленки, где указанный матрикс пленки включает:a) привитый сополимер поливинилового спирта-полиэтиленгликоля (PVA-PEG привитый сополимер) как водораствиоримый матриксный сополимер;b) активный ингредиент, который является стероидным эстрогеном; и указанный пленочный матрикс имеет толщину менее 300 мкм.
UAA201010636A 2008-02-13 2009-02-10 Единичная дозированная форма, которая включает привитый сополимер поливинилового спирта-полиэтиленгликоля и стероидный эстроген UA102680C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08002633 2008-02-13
PCT/EP2009/000904 WO2009100871A2 (en) 2008-02-13 2009-02-10 Drug delivery system with stabilising effect

Publications (1)

Publication Number Publication Date
UA102680C2 true UA102680C2 (ru) 2013-08-12

Family

ID=39365963

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201010636A UA102680C2 (ru) 2008-02-13 2009-02-10 Единичная дозированная форма, которая включает привитый сополимер поливинилового спирта-полиэтиленгликоля и стероидный эстроген

Country Status (27)

Country Link
US (1) US20110097405A1 (ru)
EP (1) EP2249803A2 (ru)
JP (1) JP2011511823A (ru)
KR (1) KR20100125309A (ru)
CN (1) CN101945646A (ru)
AR (1) AR070375A1 (ru)
AU (1) AU2009214193A1 (ru)
BR (1) BRPI0908477A2 (ru)
CA (1) CA2714340A1 (ru)
CL (1) CL2009000326A1 (ru)
CO (1) CO6290633A2 (ru)
CR (1) CR11632A (ru)
DO (1) DOP2010000252A (ru)
EA (1) EA201001245A1 (ru)
EC (1) ECSP10010400A (ru)
IL (1) IL206640A0 (ru)
MA (1) MA32073B1 (ru)
MX (1) MX2010008940A (ru)
NZ (1) NZ586666A (ru)
PA (1) PA8816001A1 (ru)
PE (1) PE20091471A1 (ru)
TN (1) TN2010000302A1 (ru)
TW (1) TW200940095A (ru)
UA (1) UA102680C2 (ru)
UY (1) UY31660A1 (ru)
WO (1) WO2009101021A2 (ru)
ZA (1) ZA201006517B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101310710B1 (ko) * 2011-03-23 2013-09-27 한미약품 주식회사 오메가-3 지방산 에스테르 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 경구용 복합 조성물
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
US10067103B2 (en) * 2015-03-02 2018-09-04 Colonaryconcepts Llc Compounds and methods for PEG metabolite and PEG breakdown product assays
CN119055659A (zh) * 2024-09-03 2024-12-03 南通大学 17α雌二醇或其化学修饰衍生物在制备预防和/或治疗男性性腺功能低下的药物中的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
ATE155681T1 (de) * 1992-05-18 1997-08-15 Minnesota Mining & Mfg Einrichtung zur transmucosalen wirkstoffabgabe
DE4426709A1 (de) * 1994-07-20 1996-01-25 Schering Ag Steroidale Sexualhormone enthaltende feste Arzneiformen
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
CN1240387C (zh) * 1998-04-17 2006-02-08 奥索一麦克尼尔药品公司 含有叶酸的药用组合物及其用途和给药系统
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
AU5834101A (en) * 2000-04-12 2001-10-23 Schering Ag 8ss-hydrocarbyl-substituted estratrienes for use as selective estrogens
EP1216712A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Cyclodextrin-drospirenone inclusion complexes
WO2002092102A2 (en) * 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
CA2476940C (en) * 2002-02-21 2011-11-01 Herman Jan Tijmen Coelingh Bennink Pharmaceutical compositions comprising one or more steroids, one or more tetrahydrofolate components and vitamin b12
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
WO2005004989A2 (en) * 2003-07-01 2005-01-20 Todd Maibach Film comprising therapeutic agents
EP1695699A4 (en) * 2003-12-09 2012-08-22 Dainippon Sumitomo Pharma Co MEDICINAL GRAINS AND THE GRAINS CONTAINING SOLID PREPARATIONS
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102004023984A1 (de) * 2004-05-14 2005-12-08 Hf Arzneimittelforschung Gmbh Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
DE102005015128B4 (de) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafer enthaltend Steroidhormone
WO2006127879A1 (en) * 2005-05-26 2006-11-30 Duramed Pharmaceuticals, Inc. Flexible solid dosage forms and methods of making and using the same
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
DE102005062270A1 (de) * 2005-12-24 2007-06-28 Bayer Technology Services Gmbh Geschmacksmaskierung von Pulvern
DE102006003512A1 (de) * 2006-01-24 2007-08-02 Bayer Schering Pharma Ag Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen
EP1867321A3 (en) * 2006-06-07 2008-11-19 Familplan Consulting Ltd. A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent
DE102006027792A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antidepressiva-Kombinations-Wafer
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
US20080058272A1 (en) * 2006-08-29 2008-03-06 Juergen Becker Nonamer Peptides for Cancer Treatment

Also Published As

Publication number Publication date
CO6290633A2 (es) 2011-06-20
WO2009101021A3 (en) 2009-12-30
ZA201006517B (en) 2014-02-26
NZ586666A (en) 2012-04-27
TW200940095A (en) 2009-10-01
TN2010000302A1 (en) 2011-11-11
JP2011511823A (ja) 2011-04-14
ECSP10010400A (es) 2010-09-30
AU2009214193A1 (en) 2009-08-20
IL206640A0 (en) 2010-12-30
AR070375A1 (es) 2010-03-31
CR11632A (es) 2010-10-05
MX2010008940A (es) 2010-10-05
CA2714340A1 (en) 2009-08-20
KR20100125309A (ko) 2010-11-30
EP2249803A2 (en) 2010-11-17
PE20091471A1 (es) 2009-10-25
WO2009101021A2 (en) 2009-08-20
UY31660A1 (es) 2009-09-30
CN101945646A (zh) 2011-01-12
MA32073B1 (fr) 2011-02-01
PA8816001A1 (es) 2009-09-17
CL2009000326A1 (es) 2010-07-19
EA201001245A1 (ru) 2011-04-29
BRPI0908477A2 (pt) 2018-03-27
DOP2010000252A (es) 2010-08-31
US20110097405A1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
MX2010008945A (es) Sistema de administracion de drogas con efecto estabilizante.
WO2010075210A3 (en) Modified perfluoropolymer sheet material and methods for making same
TW200743661A (en) Adhesive sheet and release sheet
TW200802889A (en) Semiconductor device and manufacturing method thereof
WO2008100375A3 (en) Polymer-based films and drug delivery systems made therefrom
UA102680C2 (ru) Единичная дозированная форма, которая включает привитый сополимер поливинилового спирта-полиэтиленгликоля и стероидный эстроген
HK1200105A1 (zh) 牙齒膜製劑
WO2007035940A3 (en) Transdermal norelgestromin delivery system
MY161056A (en) Dental strip for administration of oral treatment
EA201270581A1 (ru) Фармацевтические композиции севеламера
TW201129669A (en) Adhesive sheet and production method of electronic parts
WO2008152398A3 (en) Formulations for inhalation
WO2011119288A3 (en) Multilayer melt-extruded film
WO2022096676A8 (en) Oral thin film
WO2011056702A3 (en) Fast dissolving/disintegrating coating compositions
EP4166618A4 (en) ADHESIVE FILM, COMPOSITION FOR FORMING THIS FILM AND ELECTRONIC DEVICE
WO2008107301A3 (fr) Film monocouche a desintegration rapide pour l'administration buccale de substances actives
WO2007141743A3 (en) A tablet dosage form comprising cetirizine and pseudoephedrine
TW200740277A (en) An active illumination apparatus and fabrication method thereof
MX2009013054A (es) Composicion farmaceutica que comprende un sustrato y un revestimiento que contiene un ingrediente activo y alcohol polivinilico.
TN2010000375A1 (en) Drug delivery system with stabilising effect
EA201001032A1 (ru) Таблетки с пленочным покрытием, содержащие в качестве активного компонента дроспиренон, и способ их получения
WO2008078727A1 (ja) 溶出性の改善された医薬組成物
GEP20094589B (en) Orally dispersible pharmaceutical composition and process for the preparation thereof
WO2011006593A3 (de) Wasserdampfdurchlässiges hautpflaster